1. Arboris BioTech AI wins Health Canada clearance for Phase 2 oncology trial (ABT:TSX) Arboris BioTech AI has received Health Canada authorization to begin a Phase 2 clinical trial for …
BiotechReporter.news is a Leads & Copy Publication
Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.
By Subscribing you will receive Daily Biotech Story Leads via email 10 am ET Mon-Fri.
BiotechReporter.news is a Leads & Copy Publication
Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.
By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.